BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 15453960)

  • 1. Tracers to monitor the response to chemotherapy: in vitro screening of four radiopharmaceuticals.
    de Geus-Oei LF; van Eerd-Vismale J; Molthoff C; Corstens F; Oyen W; Boerman O
    Cancer Biother Radiopharm; 2004 Aug; 19(4):457-65. PubMed ID: 15453960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P-glycoprotein versus MRP1 on transport kinetics of cationic lipophilic substrates: a comparative study using [99mTc]sestamibi and [99mTc]tetrofosmin.
    Gomes CM; Abrunhosa AJ; Pauwels EK; Botelho MF
    Cancer Biother Radiopharm; 2009 Apr; 24(2):215-27. PubMed ID: 19409044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ANTIPSYCHOTICS REVERSE P-GLYCOPROTEIN-MEDIATED DOXORUBICIN RESISTANCE IN HUMAN UTERINE SARCOMA MES-SA/Dx5 CELLS: A NOVEL APPROACH TO CANCER CHEMOTHERAPY.
    Angelini A; Ciofani G; Conti P
    J Biol Regul Homeost Agents; 2015; 29(2):357-65. PubMed ID: 26122223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioiodinated agents for imaging multidrug resistant tumors.
    Kortylewicz ZP; Augustine AM; Nearman J; McGarry J; Baranowska-Kortylewicz J
    Med Chem; 2009 Mar; 5(2):171-81. PubMed ID: 19275716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limitations of (99m)Tc tetrofosmin in assessing reversal effects of verapamil on the function of multi-drug resistance associated protein 1.
    Kinuya S; Li XF; Yokoyama K; Mori H; Shiba K; Watanabe N; Shuke N; Bunko H; Michigishi T; Tonami N
    Nucl Med Commun; 2004 Jun; 25(6):585-9. PubMed ID: 15167518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of doxorubicin, etoposide, vinblastine, and taxol resistance in multidrug resistant human sarcoma cells by a polymer of spermine.
    Gosland MP; Gillespie MN; Tsuboi CP; Tofiq S; Olson JW; Crooks PA; Aziz SM
    Cancer Chemother Pharmacol; 1996; 37(6):593-600. PubMed ID: 8612315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stable suppression of MDR-1 gene using siRNA expression vector to reverse drug resistance in a human uterine sarcoma cell line.
    Hua J; Mutch DG; Herzog TJ
    Gynecol Oncol; 2005 Jul; 98(1):31-8. PubMed ID: 15921732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
    Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH
    Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel technetium (III)-Q complexes for functional imaging of multidrug resistance (MDR1) P-glycoprotein.
    Crankshaw CL; Marmion M; Luker GD; Rao V; Dahlheimer J; Burleigh BD; Webb E; Deutsch KF; Piwnica-Worms D
    J Nucl Med; 1998 Jan; 39(1):77-86. PubMed ID: 9443741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of multidrug resistance p-glycoprotein activity by flavonoids and honokiol in human doxorubicin- resistant sarcoma cells (MES-SA/DX-5): implications for natural sedatives as chemosensitizing agents in cancer therapy.
    Angelini A; Di Ilio C; Castellani ML; Conti P; Cuccurullo F
    J Biol Regul Homeost Agents; 2010; 24(2):197-205. PubMed ID: 20487633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic and multidrug resistance reversal activities of novel 1,4-dihydropyridines against human cancer cells.
    Shekari F; Sadeghpour H; Javidnia K; Saso L; Nazari F; Firuzi O; Miri R
    Eur J Pharmacol; 2015 Jan; 746():233-44. PubMed ID: 25445037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysosomal accumulation of drugs in drug-sensitive MES-SA but not multidrug-resistant MES-SA/Dx5 uterine sarcoma cells.
    Wang E; Lee MD; Dunn KW
    J Cell Physiol; 2000 Aug; 184(2):263-74. PubMed ID: 10867652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging recognition of inhibition of multidrug resistance in human breast cancer xenografts using 99mTc-labeled sestamibi and tetrofosmin.
    Liu Z; Stevenson GD; Barrett HH; Furenlid LR; Wilson DW; Kastis GA; Bettan M; Woolfenden JM
    Nucl Med Biol; 2005 Aug; 32(6):573-83. PubMed ID: 16026704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technetium-99m-tetrofosmin would be a substrate for multidrug resistance-associated protein (MRP): comparison between a leukemia cell line with high MRP gene expression and its parental cell line.
    Li XF; Kinuya S; Yokoyama K; Konishi S; Ma YY; Watanabe N; Shuke N; Bunko H; Michigishi T; Tonami N
    Cancer Biother Radiopharm; 2001 Feb; 16(1):17-23. PubMed ID: 11279794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of multidrug resistance P-glycoprotein activity by antiemetic compounds in human doxorubicin-resistant sarcoma cells (MES-SA/Dx-5): implications on cancer therapy.
    Angelini A; Conti P; Ciofani G; Cuccurullo F; Di Ilio C
    J Biol Regul Homeost Agents; 2013; 27(4):1029-37. PubMed ID: 24382184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Verapamil decreases accumulation of 99Tcm-MIBI and 99Tcm-tetrofosmin in human breast cancer and soft tissue sarcoma cell lines.
    Rodrigues M; Kalinowska W; Zielinski C; Sinzinger H
    Nucl Med Commun; 2001 Jun; 22(6):645-50. PubMed ID: 11403175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative 99mTc-MIBI, 99mTc-tetrofosmin and 99mTc-furifosmin uptake in human soft tissue sarcoma cell lines.
    Rodriques M; Chehne F; Kalinowska W; Zielinski C; Sinzinger H
    Eur J Nucl Med; 2000 Dec; 27(12):1839-43. PubMed ID: 11189948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitation of doxorubicin uptake, efflux, and modulation of multidrug resistance (MDR) in MDR human cancer cells.
    Shen F; Chu S; Bence AK; Bailey B; Xue X; Erickson PA; Montrose MH; Beck WT; Erickson LC
    J Pharmacol Exp Ther; 2008 Jan; 324(1):95-102. PubMed ID: 17947497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
    Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW
    J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of tea polyphenol as a reversal agent for carcinoma cell lines' multidrug resistance (study of TP as a MDR reversal agent).
    Zhu A; Wang X; Guo Z
    Nucl Med Biol; 2001 Aug; 28(6):735-40. PubMed ID: 11518657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.